LivaNova PLC said the U.S. Food and Drug Administration granted 510(k) clearance to its medical implant Memo 4D, a semi-rigid ring used for treating a type of heart condition.

The London-based medical device maker said the Memo 4D is a semi-rigid mitral annuloplasty ring to treat mitral regurgitation, a disorder of the heart in which the mitral valve does not close properly when the heart pumps out blood.

Mitral valve annuloplasty is a surgical technique for the repair of leaking mitral valves.